Application

17529155 · INHALABLE DRY POWDER FORMULATIONS COMPRISING ANGIOGENESIS INHIBITORS

Filed 2021-11-17 · Abandoned The official file ↗ · Art unit 1612 · Examiner Gollamudi S Kishore Hard · CPC A61K 9/0075 · Bend Research, Inc. · Klarquist Sparkman, LLP (Bend Research)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

9.2 mo

to disposition 32.5 mo

Statutes raised

102 103

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.